familymednews.com
People who had recently used psychedelics such as psilocybin report a sustained improvement in mood and feeling closer to others after the high has worn off, shows a new Yale study published the week of Jan. 20 in the journal Proceedings of the National Academy of Sciences. The results of a field study of more than 1,200 people attending multi-day […]
Continue reading »
Regular screening mammograms are unlikely to benefit women 75 and older who have chronic illnesses such as cardiovascular disease or diabetes. New data suggest they would likely die due to other health conditions before they developed breast cancer. That is the finding of a new study based on data from more than 220,000 women that was published September 6, 2019, […]
Continue reading »
Teen depression can affect parents’ marital satisfaction, a new Northwestern Medicine study has found. Parents often seek mental health treatment for a child struggling with depression, but the treatment shouldn’t stop with the depressed teen, suggests the study. The study found that while depressed teens were involved in active treatment, parents’ marriages and parent-child conflict remained stable. Once the teens’ […]
Continue reading »
People who are mentally ill are 2.4 times more likely than claimants with non-psychiatric conditions to lose their existing benefit following a Personal Independence Payment (PIP) eligibility assessment, research has found. Published in the British Journal of Psychiatry Open, the study from the University of York analysed government data of claimants moving from an existing Disability Living Allowance (DLA) entitlement […]
Continue reading »
Parents who are anxious about math can still help their children learn the subject when given the right tools, according to research from current and former University of Chicago scholars. A new study published in the December issue of the Journal of Experimental Psychology found that math-anxious parents who used an app called Bedtime Math saw improvement in their children’s […]
Continue reading »
New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalised medicine ever nearer. Professor Laura van ‘t Veer, leader of the Breast Oncology Program at the University of California San Francisco, USA, told the […]
Continue reading »
Benefit has a new model to keep product flowing to its influencer base. The brand, known for its brow products, is launching a button to help ensure Benefit influencers stay stocked with product while simultaneously cutting down on excess packaging. The idea was inspired by influencers who communicated to Benefit that they were out of product, as well as influencers and editors […]
Continue reading »
For some patients with difficult-to-treat leukemia and lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, according to phase III trial data published today in the journal Blood. The DUO trial studied the head-to-head comparison of duvelisib versus ofatumumab, an approved standard-of-care chemotherapy for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). According to […]
Continue reading »
Logically, it would seem that more follow-up testing of cancer patients must be better—but this is not the case for patients who undergo surgery for colorectal cancer. This is an important conclusion from a study in which 2,509 patients with colorectal cancer were offered two and five follow-up tests in the form of CT scans combined with a blood test […]
Continue reading »
New findings from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx), or TAILORx trial, show no benefit from chemotherapy for 70 percent of women with the most common type of breast cancer. The study found that for women with hormone receptor (HR)-positive, HER2-negative, axillary lymph node¬-negative breast cancer, treatment with chemotherapy and hormone therapy after surgery is not more […]
Continue reading »